What is the purpose of this capital reduction?

It is intended for the cancellation of restricted employee shares.

What are the main numerical changes?

A reduction in paid-in capital and outstanding shares, resulting in an adjustment to net value per share.

Where can the impact be verified?

It is reflected in the consolidated financial statements for Q1 and the approval letter for the registration change.

AI News NQ Analysis

[Bora] Announcement regarding the completion of registration for capital reduction via cancellation of restricted employee shares

NQ Score 80/100

N1 Content Completeness 5

AI Summary (NQ-processed)

Bora Pharmaceuticals announced that on May 20, 2026, it completed the registration for a capital reduction due to the cancellation of restricted employee shares. The paid-in capital has been adjusted to NT$1,277,413,590, with outstanding shares totaling 127,741,359.

AI Analysis

Frequently Asked Questions

Q: What is the purpose of this capital reduction?: A: It is intended for the cancellation of restricted employee shares.
Q: What are the main numerical changes?: A: A reduction in paid-in capital and outstanding shares, resulting in an adjustment to net value per share.
Q: Where can the impact be verified?: A: It is reflected in the consolidated financial statements for Q1 and the approval letter for the registration change.